Characterization of the severity of dyspnea in patients with bronchiectasis: correlation with clinical, functional, and tomographic aspects
- PMID: 32556031
- PMCID: PMC7572272
- DOI: 10.36416/1806-3756/e20190162
Characterization of the severity of dyspnea in patients with bronchiectasis: correlation with clinical, functional, and tomographic aspects
Abstract
Objective: To characterize a population of patients with bronchiectasis, correlating clinical, radiological, and functional aspects with the severity of dyspnea.
Methods: This was a cross-sectional study involving adult patients with HRCT-confirmed bronchiectasis, categorized according to the severity of dyspnea (as being mildly or severely symptomatic, on the basis of the modified Medical Research Council scale). We correlated the severity of dyspnea with clinical parameters, functional parameters (spirometry values, lung volumes, and DLCO), and CT parameters.
Results: We evaluated 114 patients, 47 (41%) of whom were men. The median age (interquartile range) was 42 years (30-55 years). The most common form was idiopathic bronchiectasis. Of the 114 patients, 20 (17.5%) were colonized with Pseudomonas aeruginosa and 59 (51.8%) were under continuous treatment with macrolides. When we applied the Exacerbation in the previous year, FEV1, Age, Colonization, Extension, and Dyspnea score, the severity of dyspnea was categorized as moderate in 54 patients (47.4%), whereas it was categorized as mild in 50 (43.9%) when we applied the Bronchiectasis Severity Index. The most common lung function pattern was one of obstruction, seen in 95 patients (83.3%), and air trapping was seen in 77 patients (68.7%). The prevalence of an obstructive pattern on spirometry was higher among the patients with dyspnea that was more severe, and most functional parameters showed reasonable accuracy in discriminating between levels of dyspnea severity.
Conclusions: Patients with bronchiectasis and dyspnea that was more severe had greater functional impairment. The measurement of lung volumes complemented the spirometry data. Because bronchiectasis is a complex, heterogeneous condition, a single variable does not seem to be sufficient to provide an overall characterization of the clinical condition.
Objetivo:: Caracterizar uma população de portadores de bronquiectasias e correlacionar aspectos clínicos, radiológicos e funcionais com a gravidade da dispneia.
Métodos:: Estudo transversal realizado em adultos, portadores de bronquiectasias confirmadas por TCAR, categorizados de acordo com a gravidade da dispneia (pacientes pouco e muito sintomáticos), correlacionando-os com seus parâmetros clínicos, funcionais (espirometria, volumes pulmonares e DLCO) e tomográficos.
Resultados:: Foram avaliados 114 pacientes (47 homens, 41%). A mediana (intervalo interquartil) de idade foi de 42 (30-55) anos. A etiologia mais frequente foi idiopática. Em relação à colonização, 20 pacientes (17,5%) eram colonizados por Pseudomonas aeruginosa e grande parte fazia uso de macrolídeo continuamente (51,8%). Quanto à gravidade da dispneia, ela foi considerada moderada em 54 pacientes (47,4%) pelo escore Exacerbation in previous year, FEV1, Age, Colonization, Extension, and Dyspnea e leve em 50 (43,9%) pelo Bronchiectasis Severity Index. O padrão funcional mais encontrado foi distúrbio ventilatório obstrutivo (em 83%), e 68% apresentavam aprisionamento aéreo. Pacientes com maior grau de dispneia apresentaram maior prevalência de distúrbio obstrutivo na espirometria, e a maioria dos parâmetros funcionais apresentaram acurácia razoável em discriminar a gravidade da dispneia.
Conclusões:: Pacientes com bronquiectasias e maior gravidade da dispneia apresentaram um comprometimento funcional mais expressivo. A medida de volumes pulmonares complementou os dados da espirometria. Por se tratar de uma condição complexa e heterogênea, uma única variável parece não ser suficiente para caracterizar a condição clínica de forma global.
Figures
Comment in
-
Dyspnea in bronchiectasis: a complex symptom of a complex disease.J Bras Pneumol. 2020 Sep 23;46(5):e20200281. doi: 10.36416/1806-3756/e20200281. J Bras Pneumol. 2020. PMID: 33027471 English, Portuguese. No abstract available.
Similar articles
-
Dissociation of lung function, dyspnea ratings and pulmonary extension in bronchiectasis.Respir Med. 2007 Nov;101(11):2248-53. doi: 10.1016/j.rmed.2007.06.028. Epub 2007 Aug 14. Respir Med. 2007. PMID: 17698334
-
Clinical characteristics, radiological features, and disease severity of bronchiectasis according to the spirometric pattern.Sci Rep. 2022 Aug 1;12(1):13167. doi: 10.1038/s41598-022-17085-3. Sci Rep. 2022. PMID: 35915114 Free PMC article.
-
Non CF-bronchiectasis: Aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patients.Respir Med. 2016 Jul;116:1-7. doi: 10.1016/j.rmed.2016.05.001. Epub 2016 May 3. Respir Med. 2016. PMID: 27296814
-
Factors associated with pulmonary hypertension and long-term survival in bronchiectasis subjects.Respir Med. 2016 Oct;119:109-114. doi: 10.1016/j.rmed.2016.08.027. Epub 2016 Aug 30. Respir Med. 2016. PMID: 27692130 Review.
-
Radiology of Bronchiectasis.Clin Chest Med. 2022 Mar;43(1):47-60. doi: 10.1016/j.ccm.2021.11.004. Clin Chest Med. 2022. PMID: 35236560 Review.
Cited by
-
Autologous transplantation of P63+ lung progenitor cells in patients with bronchiectasis: A randomized, single-blind, controlled trial.Cell Rep Med. 2024 Nov 19;5(11):101819. doi: 10.1016/j.xcrm.2024.101819. Cell Rep Med. 2024. PMID: 39566467 Free PMC article. Clinical Trial.
-
Biomarkers in bronchiectasis.Eur Respir Rev. 2024 Jul 3;33(173):230234. doi: 10.1183/16000617.0234-2023. Print 2024 Jul. Eur Respir Rev. 2024. PMID: 38960612 Free PMC article. Review.
-
Effect of Dual Bronchodilation on the Exercise Capacity of Individuals With Non-Cystic Fibrosis Bronchiectasis: Protocol for a Randomized Controlled Double-Blind Crossover Study.JMIR Res Protoc. 2025 Jul 28;14:e68582. doi: 10.2196/68582. JMIR Res Protoc. 2025. PMID: 40720815 Free PMC article.
-
Towards a new definition of non-cystic fibrosis bronchiectasis.J Bras Pneumol. 2022 Feb 2;48(1):e20220023. doi: 10.36416/1806-3756/e20220023. J Bras Pneumol. 2022. PMID: 35137878 Free PMC article. No abstract available.
-
Correlating Reiff scores with clinical, functional, and prognostic factors: characterizing noncystic fibrosis bronchiectasis severity: validation from a nationwide multicenter study in Taiwan.Eur J Med Res. 2024 May 14;29(1):286. doi: 10.1186/s40001-024-01870-z. Eur J Med Res. 2024. PMID: 38745338 Free PMC article.